RPS6 and hereditary hemorrhagic telangiectasia: In accordance with PI3K activation, mTORC1 has been recorded to be activated in tissues of HHT patients as well as in HHT2 mouse models, inferred by increased levels of phosphorylated RPS6, a S6K1 target [9, 11, 12, 14, 15].